MARKET

VALN

VALN

Valneva Se
NASDAQ
8.14
-0.10
-1.21%
After Hours: 8.14 0 0.00% 16:04 12/18 EST
OPEN
8.31
PREV CLOSE
8.24
HIGH
8.35
LOW
8.10
VOLUME
11.62K
TURNOVER
--
52 WEEK HIGH
12.25
52 WEEK LOW
3.620
MARKET CAP
698.94M
P/E (TTM)
-11.3576
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VALN last week (1208-1212)?
Weekly Report · 3d ago
Market Pulse: Tilray Leads After-Hours Rally As Biotech Peers Surge
NASDAQ · 3d ago
Valneva (0OB3) Gets a Buy from Kepler Capital
TipRanks · 5d ago
Valneva Reports Positive Phase 2 Results for Chikungunya Vaccine in Children
TipRanks · 12/11 11:43
Valneva reports ‘positive’ final Phase 2 results for chikungunya vaccine
TipRanks · 12/10 16:50
Valneva Reports Strong Twelve-Month Antibody Response in Children for Chikungunya Vaccine IXCHIQ
Reuters · 12/10 16:45
VALNEVA REPORTS POSITIVE FINAL PHASE 2 ANTIBODY PERSISTENCE AND SAFETY RESULTS IN CHILDREN FOR ITS CHIKUNGUNYA VACCINE IXCHIQ®
Reuters · 12/10 16:45
VALNEVA SE - 94.7% SERORESPONSE RATE IN CHIKV-NAÏVE CHILDREN (FULL DOSE) AT DAY 360
Reuters · 12/10 16:45
More
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Webull offers Valneva SE (ADR) stock information, including NASDAQ: VALN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VALN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VALN stock methods without spending real money on the virtual paper trading platform.